Cargando…

Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials

Background: Given their changing pathophysiology, elderly patients carry a high risk of embolism and bleeding events; hence, use of appropriate anticoagulants is very important. Low molecular weight heparin (LMWH) is one of the most widely used anticoagulants although LMWHs differ in their anti-Xa,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hui-qin, Liu, Man-cang, Yin, Wen-jun, Zhou, Ling-yun, Zuo, Xiao-cong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703065/ https://www.ncbi.nlm.nih.gov/pubmed/34955853 http://dx.doi.org/10.3389/fphar.2021.783104

Ejemplares similares

The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
por: Wei, Matthew Y., et al.
Publicado: (2015)

Low molecular weight heparin in COVID-19: benefits and concerns
por: Makarem, Adham, et al.
Publicado: (2023)

Comparison of low-molecular-weight heparins in thromboprophylaxis of major orthopaedic surgery – randomized, prospective pilot study
por: Biławicz, Jan, et al.
Publicado: (2020)

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
por: Paolisso, Pasquale, et al.
Publicado: (2020)

Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database
por: Liu, Leping, et al.
Publicado: (2023)

Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl(4)-Induced Liver Fibrosis
por: Yan, Yishu, et al.
Publicado: (2017)

Case Report: Spontaneous Intramural Hematoma of the Colon Secondary to Low Molecular Weight Heparin Therapy
por: Zhu, Ye, et al.
Publicado: (2021)

Low molecular-weight heparin for thromboprophylaxis in patients undergoing gastric cancer surgery: an experience from one Korean institute
por: Choi, Sung Ho, et al.
Publicado: (2014)

Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis
por: Kumar, Arun, et al.
Publicado: (2019)

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
por: Ferrandis, R., et al.
Publicado: (2023)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial
por: Pai, Menaka, et al.
Publicado: (2018)

Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials
por: Ena, Javier, et al.
Publicado: (2022)

Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis
por: Huang, Hai-Feng, et al.
Publicado: (2018)

THROMBOTECT – a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents
por: Greiner, Jeanette, et al.
Publicado: (2019)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)

High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin
por: Asperti, Michela, et al.
Publicado: (2016)

TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial
por: Klaassen, Irene L. M., et al.
Publicado: (2017)

Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial
por: Auer, Rebecca C, et al.
Publicado: (2022)

Postpartum Heparin Thromboprophylaxis: More Harm Than Good
por: Kotaska, Andrew
Publicado: (2021)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Efficacy and Safety of Low-Molecular-Weight Heparins As An Adjunct to Thrombolysis in Acute ST-Elevation Myocardial Infarction
por: Rubboli, Andrea
Publicado: (2008)

The Safety and Efficacy of Low-Molecular-Weight Heparin in Pregnant Women With Rheumatic Heart Disease and Valves Replacement
por: Alghamdi, Najwa, et al.
Publicado: (2022)

A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients
por: Giossi, Riccardo, et al.
Publicado: (2021)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Efficacy and Safety of Thromboprophylaxis Post-Orthopedic Surgery
por: Alsheikh, Khalid, et al.
Publicado: (2021)

Extended versus inpatient thromboprophylaxis with heparins following major open abdominopelvic surgery for malignancy: a systematic review of efficacy and safety
por: Heijkoop, B., et al.
Publicado: (2020)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?
por: Gurjar, Mohan
Publicado: (2014)

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
por: Lazrak, Hind Harrak, et al.
Publicado: (2017)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Comparison of modified versus conventional injection techniques of low-molecular-weight heparin in elderly
por: Geng, Wenzhen, et al.
Publicado: (2018)

Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
por: Mattioli, Massimo, et al.
Publicado: (2020)

Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials
por: Fan, Yu, et al.
Publicado: (2016)

Comparison of the Efficacy and Safety of Aspirin and Low-Molecular-Weight Heparin in Patients With a Fracture: A Meta-Analysis
por: Nimerta, FNU, et al.
Publicado: (2023)

Safety and effectiveness of fondaparinux as a postpartum thromboprophylaxis during puerperium among muslim women: A single centre prospective study
por: Muhamad, Normaliza, et al.
Publicado: (2022)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
por: Ma, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0t8ld869ldtfuq54qamt4v1pmb